PILL:NYE-Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 7

Change

-0.26 (-3.58)%

Market Cap

N/A

Volume

0.06M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-11 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

-0.58 (-3.22%)

USD 8.29B
QLD ProShares Ultra QQQ

-0.66 (-0.73%)

USD 8.27B
SSO ProShares Ultra S&P500

-1.38 (-1.66%)

USD 5.76B
FNGU MicroSectors FANG+ Index 3X Le..

N/A

USD 5.57B
UPRO ProShares UltraPro S&P500

-1.88 (-2.51%)

USD 4.34B
TECL Direxion Daily Technology Bull..

-0.86 (-1.39%)

USD 2.48B
YINN Direxion Daily FTSE China Bull..

+1.67 (+3.91%)

USD 1.91B
USD ProShares Ultra Semiconductors

+0.80 (+1.91%)

USD 1.16B
UDOW ProShares UltraPro Dow30

-3.13 (-3.54%)

USD 0.77B
LABU Direxion Daily S&P Biotech Bul..

-0.40 (-0.53%)

USD 0.77B

ETFs Containing PILL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.41% 57% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.41% 57% F 45% F
Trailing 12 Months  
Capital Gain -13.04% 34% F 19% F
Dividend Return 0.97% 55% F 16% F
Total Return -12.07% 34% F 17% F
Trailing 5 Years  
Capital Gain -46.03% 16% F 8% B-
Dividend Return 2.16% 19% F 4% F
Total Return -43.87% 16% F 7% C-
Average Annual (5 Year Horizon)  
Capital Gain 56.65% 79% B- 95% A
Dividend Return 57.24% 79% B- 94% A
Total Return 0.60% 41% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 393.04% 15% F 3% F
Risk Adjusted Return 14.56% 27% F 30% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.